11.12.2012 Views

NASA Scientific and Technical Aerospace Reports

NASA Scientific and Technical Aerospace Reports

NASA Scientific and Technical Aerospace Reports

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>and</strong> loss of heterozygosity occurs in TSC tumors. Tuberin <strong>and</strong>/or hamartin appear to be involved in multiple cellular pathways:<br />

vesicular trafficking, signaling via the small GTPase Rap 1, cell cycle regulation, steroid hormone function, cell adhesion via<br />

the small GTPase Rho, <strong>and</strong> signaling via ribosomal protein S6 <strong>and</strong> MTOR, which regulate protein synthesis <strong>and</strong> cell growth.<br />

The in vivo importance of these different activities <strong>and</strong> their contributions to human TSC are not yet entirely understood.<br />

DTIC<br />

Convulsions; Genes; Steroids<br />

20040111667 Washington Univ., Seattle, WA<br />

Clinical <strong>and</strong> Molecular Consequences of NF1 Microdeletion<br />

Stephens, Karen; May 2004; 33 pp.; In English<br />

Contract(s)/Grant(s): DAMD17-03-1-0203<br />

Report No.(s): AD-A425784; No Copyright; Avail: CASI; A03, Hardcopy<br />

Skin neurofibromas are the most common tumors of patients with neurofibromatosis type 1 (NF1), yet we know very little<br />

about how they develop. We are studying NF1 subjects with microdeletions because they are predisposed to large numbers<br />

of neurofibromas. We propose that deletion of NF1 gene <strong>and</strong> one of the 15 adjacent genes favors the development of skin<br />

neurofibromas, <strong>and</strong> possibly also other tumors. We are currently evaluating NF1 subjects to identify those with deletions <strong>and</strong><br />

determine when <strong>and</strong> what kind of tumors <strong>and</strong> other clinical features they develop. We have developed new competitive PCR<br />

assays to rapidly screen for deletion patients. Later in the study we, will look for specific genetic changes in skin<br />

neurofibromas of patients with NF1 deletions to provide insight into how they develop. We propose to employ new <strong>and</strong><br />

powerful technology from the Human Genome Project to confirm or disprove the presence of a t<strong>and</strong>em NF1-like gene. If<br />

present, this gene may contribute in some unknown way to making the disease more or less severe. Therefore, identifying a<br />

tumor modelling gene <strong>and</strong> the possible t<strong>and</strong>em NF1-like gene will help us underst<strong>and</strong> tumorigenesis in these patients.<br />

DTIC<br />

Cells (Biology); Genetics<br />

20040111668 California Univ., Berkeley, CA<br />

TGF-B Regulation of the Mammary Radiation Response<br />

Pajares, Maria J.; Dec. 2003; 32 pp.; In English<br />

Contract(s)/Grant(s): DAMD17-01-1-0291<br />

Report No.(s): AD-A425786; No Copyright; Avail: CASI; A03, Hardcopy<br />

Transforming growth factor beta 1 (TGF-beta 1) orchestrates the response of different cell types to injury via regulation<br />

of proliferation, apoptosis <strong>and</strong> ECM composition. Previously we discovered that TGF beta 1 is rapidly activated in mammary<br />

gl<strong>and</strong> following radiation. Because TGF- beta 1 is implicated in regulation of proliferation <strong>and</strong> apoptosis, we investigated<br />

whether the activation of TGF-beta 1 contributes to the cell fate decisions in response to radiation. We found that<br />

radiation-induced apoptosis <strong>and</strong> cycle cell arrest are absent in adult mammary epithelium <strong>and</strong> embryonic liver <strong>and</strong> epidermis<br />

when TGF-beta 1 is compromised. Since p53 abundance <strong>and</strong> activity is thought to dictate apoptotic cellular responses to<br />

radiation, we examined the p53 response. We found that both chronic <strong>and</strong> transient depletion of TGF-beta 1 compromise the<br />

p53 response. In order to study the mechanism by which TGF-beta 1 affects the p53 response we cultured mammary epithelial<br />

cells (MECs). This in vitro model present TGF-beta 1 dependent radiation response similar to that seen in vivo. Treatment of<br />

MECs with TGF-beta 1 restored both p53 response <strong>and</strong> caspase 3 cleavage in the heterozygote cultures. We propose that<br />

TGF-beta 1 is a key regulator of epithelial genomic integrity since its loss impairs activation of p53 resulting in reduced<br />

apoptosis <strong>and</strong> cell cycle arrest.<br />

DTIC<br />

Mammary Gl<strong>and</strong>s<br />

20040111670 Albany Medical Coll., NY<br />

Breast Cancer Research Undergraduate Summer Training Program<br />

Andersen, Thomas; Jun. 2004; 34 pp.; In English<br />

Contract(s)/Grant(s): DAMD17-01-1-0121<br />

Report No.(s): AD-A425791; No Copyright; Avail: CASI; A03, Hardcopy<br />

It is important to recruit a cadre of talented investigators whose careers are dedicated to studies of prevention, treatment,<br />

<strong>and</strong> early detection of breast cancer. By investing in young people before they make career choices, <strong>and</strong> by providing them<br />

with first-h<strong>and</strong> experience in modern breast cancer research (BCR) laboratories, we are finding that several of these young<br />

201

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!